FEMHEALTH USA INC
AI Summary
FEMHEALTH USA INC, operating with an annual budget of $13.5 million and total revenue of $10.6 million, is dedicated to advancing reproductive health care. The organization is supported by multiple funders, none of which provide 50% or more of its revenue, ensuring a diverse funding base. More information about its mission and programs can be found on its website, www.carafem.org.
Mission Statement
SEE PART III, LINE 1.
Cause Areas
1
Reproductive health care
Explore this org's ecosystem
See similar nonprofits by cause and location, their funders, and their grants.
Explore this org's ecosystem
See similar nonprofits by cause and location, their funders, and their grants.
Charity Verification Snapshot
IRS EO Business Master File Status
Listed as tax-exempt
IRS Pub 78 Status
Eligible for tax-deductible gifts
IRS Revocation Status
Not in Automatic Revocation of Exemption List
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Frequently Asked Questions
What is FEMHEALTH USA INC’s budget?
In 2024, FEMHEALTH USA INC reported an annual operating budget of around $13.5 million. More detailed financial information is available to registered users.
What causes does FEMHEALTH USA INC support?
FEMHEALTH USA INC supports work in Reproductive health care.
Where does FEMHEALTH USA INC operate?
FEMHEALTH USA INC is headquartered in Washington, DC.
Who funded FEMHEALTH USA INC recently?
In 2024, FEMHEALTH USA INC received grants from THE KLE FOUNDATION, FIDELITY INVESTMENTS CHARITABLE GIFT FUND, and THE WILLIAM & FLORA HEWLETT FOUNDATION. More information on this organization’s funders is available to registered users.
What is the largest grant FEMHEALTH USA INC received in 2024?
The largest grant to FEMHEALTH USA INC in 2024 exceeds $502 thousand.
What is FEMHEALTH USA INC’s reliance on government grants?
FEMHEALTH USA INC relied on government grants for less than 5% of their total revenue in 2024.